These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 13428534)
21. The oral therapy of diabetes mellitus remedia Hoechst rastinon; information arranged and published. HOECHST F Cyprus Med J; 1956; 8(7-8):352-61. PubMed ID: 13384043 [No Abstract] [Full Text] [Related]
22. Studies on the mechanism of action of orinase (tolbutamide). VAUGHAN M Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412 [No Abstract] [Full Text] [Related]
23. Effects of tolbutamide and carbutamide on thyroid function. BROWN J; SOLOMON DH Metabolism; 1956 Nov; 5(6 Part 2):813-9. PubMed ID: 13378051 [No Abstract] [Full Text] [Related]
24. The mechanism of action of the sulfonylureas in diabetes mellitus. LEVINE R; SOBEL GW Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633 [No Abstract] [Full Text] [Related]
25. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related]
26. New orally effective adjuvants in the management of diabetes mellitus. O'DONOVAN CJ J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693 [No Abstract] [Full Text] [Related]
30. Some observations on the mode of action of orinase. ARAI Y; ELRICK H; HLAD C; PRATT E; PURNELL R Metabolism; 1956 Nov; 5(6 Part 2):778-87. PubMed ID: 13378047 [No Abstract] [Full Text] [Related]
31. Physiologic actions of orinase and their relationship to the types of diabetes in man. KARK RM; MOORHOUSE JA Metabolism; 1956 Nov; 5(6 Part 2):847-63. PubMed ID: 13378054 [No Abstract] [Full Text] [Related]
32. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
33. The hypoglucemic sulfonylurea drugs; an interim evaluation. STETTEN D Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912 [No Abstract] [Full Text] [Related]
34. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
36. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related]
38. Hypoglycaemic sulphonamides in the management of diabetes mellitus. DOWNIE E; BORNSTEIN J; HUDSON B Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634 [No Abstract] [Full Text] [Related]
39. The value of BZ 55 in control of diabetes. MURRAY I; WANG I Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512 [No Abstract] [Full Text] [Related]
40. BZ 55 and D 860 in the treatment of diabetes mellitus. SCHNEIDER T; POLITZER WM S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]